The Impact of ABCB1 Gene Polymorphism on Steroid Responsiveness in Acute Rejection in Kidney Transplantation

The Impact of ABCB1 Gene Polymorphism on Steroid Responsiveness in Acute Rejection in Kidney Transplantation Han Ro, M.D., Sang-Il Min, M.D., Jong Cheol Jeong, M.D., Tai Yeon Koo, M.D., Jaeseok Yang, M.D., Jongwon Ha, M.D. and Curie Ahn, M.D. Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University of Medicine and Science, Incheon, Transplantation Research Institute, Department of Surgery, Seoul National University College of Medicine, Transplantation Center, Seoul National University Hospital, Seoul National University College of Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea

[1]  V. Haufroid,et al.  Donor age and ABCB1 1199G>A genetic polymorphism are independent factors affecting long-term renal function after kidney transplantation. , 2012, The Journal of surgical research.

[2]  M. Simmonds,et al.  Donor ABCB1 variant associates with increased risk for kidney allograft failure. , 2012, Journal of the American Society of Nephrology : JASN.

[3]  N. Prasad,et al.  MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  E. Seidman,et al.  Associations between variants in the ABCB1 (MDR1) gene and corticosteroid dependence in children with Crohn's disease , 2011, Inflammatory bowel diseases.

[5]  H. Cheong,et al.  Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome , 2011, Pediatric Nephrology.

[6]  K. Moon,et al.  CYP3A5 *1 Allele: Impacts on Early Acute Rejection and Graft Function in Tacrolimus-Based Renal Transplant Recipients , 2010, Transplantation.

[7]  E. Coto,et al.  Pharmacogenetics of Calcineurin Inhibitors in Renal Transplantation , 2009, Transplantation.

[8]  N. Perico,et al.  ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome. , 2009, Journal of the American Society of Nephrology : JASN.

[9]  E. Novotná,et al.  Haplotypic Structure of ABCB1/MDR1 Gene Modifies the Risk of the Acute Allograft Rejection in Renal Transplant Recipients , 2008, Transplantation.

[10]  T. Habuchi,et al.  Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients , 2008, Steroids.

[11]  V. Haufroid,et al.  Biotransformation Enzymes and Drug Transporters Pharmacogenetics in Relation to Immunosuppressive Drugs: Impact on Pharmacokinetics and Clinical Outcome , 2008, Transplantation.

[12]  Shori Takahashi,et al.  Multiple drug‐resistant gene 1 in children with steroid‐sensitive nephrotic syndrome , 2008, Pediatrics international : official journal of the Japan Pediatric Society.

[13]  V. Haufroid,et al.  1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation , 2007, Pharmacogenetics and genomics.

[14]  Lippincott-Schwartz,et al.  Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .

[15]  K. Gendzekhadze,et al.  Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha -308 single nucleotide polymorphisms: a preliminary study. , 2006, Transplant immunology.

[16]  A. Wasilewska,et al.  Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response , 2006, Pediatric Nephrology.

[17]  Philip F Halloran,et al.  Immunosuppressive drugs for kidney transplantation. , 2004, The New England journal of medicine.

[18]  M. Fromm,et al.  Identification of Budesonide and Prednisone as Substrates of the Intestinal Drug Efflux Pump P-glycoprotein , 2004, Inflammatory bowel diseases.

[19]  D. Shen,et al.  Multidrug Resistance Gene G1199A Polymorphism Alters Efflux Transport Activity of P-Glycoprotein , 2004, Journal of Pharmacology and Experimental Therapeutics.

[20]  M. Fromm,et al.  Genetic polymorphisms of the human MDR1 drug transporter. , 2003, Annual review of pharmacology and toxicology.

[21]  H. Izumi,et al.  The basic and clinical implications of ABC transporters, Y‐box‐binding protein‐1 (YB‐1) and angiogenesis‐related factors in human malignancies , 2003, Cancer science.

[22]  U. Brinkmann,et al.  Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. , 2002, Journal of the American Society of Nephrology : JASN.

[23]  T. Theruvath,et al.  Strategies to improve long-term outcomes after renal transplantation. , 2002, The New England journal of medicine.

[24]  G. Braden,et al.  Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[25]  D. Ellison,et al.  Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.

[26]  C. Hawley,et al.  EFFECT OF OKT3 IN STEROID‐RESISTANT RENAL TRANSPLANT REJECTION , 1995, Transplantation.

[27]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  V. Álvarez,et al.  Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes , 2011 .

[29]  T. Sakaeda.  MDR1 genotype-related pharmacokinetics: fact or fiction? , 2005, Drug metabolism and pharmacokinetics.